CANCER OF THE PROSTATE
Clinical trials for CANCER OF THE PROSTATE explained in plain language.
Never miss a new study
Get alerted when new CANCER OF THE PROSTATE trials appear
Sign up with your email to follow new studies for CANCER OF THE PROSTATE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for men with prostate cancer: drug delays spread by months
Disease control CompletedThis study tested a drug called enzalutamide in 1401 men with a type of prostate cancer that has not spread to other parts of the body but is no longer controlled by standard hormone therapy. The goal was to see if enzalutamide could delay the cancer from spreading. Participants …
Matched conditions: CANCER OF THE PROSTATE
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Radioactive therapy shows promise for tough prostate cancer
Disease control CompletedThis phase 2 trial tested whether adding a radioactive drug (I-131-1095) to standard enzalutamide therapy helps men with a specific type of advanced prostate cancer that had worsened on another treatment. The study enrolled 120 men with PSMA-positive metastatic castration-resista…
Matched conditions: CANCER OF THE PROSTATE
Phase: PHASE2 • Sponsor: Progenics Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Real-World data reveals treatment patterns for advanced prostate cancer
Knowledge-focused CompletedThis study reviewed medical records from over 1,300 men with metastatic prostate cancer that still responds to hormone therapy. Researchers wanted to see how long patients actually take the pills apalutamide or enzalutamide when prescribed by their own doctors in routine care. Th…
Matched conditions: CANCER OF THE PROSTATE
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC